Ligand Pharmaceuticals Inc (LGND)
70.57
+0.20
(+0.28%)
USD |
NASDAQ |
Apr 26, 16:00
70.57
0.00 (0.00%)
After-Hours: 20:00
Ligand Pharmaceuticals Gross Profit Margin (Quarterly): 94.16% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 94.16% |
| September 30, 2023 | 89.40% |
| June 30, 2023 | 93.67% |
| March 31, 2023 | 91.55% |
| December 31, 2022 | 57.10% |
| September 30, 2022 | 76.10% |
| June 30, 2022 | 75.34% |
| March 31, 2022 | 87.13% |
| December 31, 2021 | 67.51% |
| September 30, 2021 | 82.35% |
| June 30, 2021 | 63.87% |
| March 31, 2021 | 85.22% |
| December 31, 2020 | 75.09% |
| September 30, 2020 | 84.82% |
| June 30, 2020 | 81.55% |
| March 31, 2020 | 85.88% |
| December 31, 2019 | 92.83% |
| September 30, 2019 | 87.31% |
| June 30, 2019 | 90.38% |
| March 31, 2019 | 91.13% |
| December 31, 2018 | 95.04% |
| September 30, 2018 | 96.80% |
| June 30, 2018 | 98.74% |
| March 31, 2018 | 98.60% |
| December 31, 2017 | 96.56% |
| Date | Value |
|---|---|
| September 30, 2017 | 92.85% |
| June 30, 2017 | 96.77% |
| March 31, 2017 | 98.83% |
| December 31, 2016 | 92.41% |
| September 30, 2016 | 95.38% |
| June 30, 2016 | 96.31% |
| March 31, 2016 | 96.78% |
| December 31, 2015 | 95.83% |
| September 30, 2015 | 92.94% |
| June 30, 2015 | 85.88% |
| March 31, 2015 | 92.64% |
| December 31, 2014 | 82.59% |
| September 30, 2014 | 90.01% |
| June 30, 2014 | 88.82% |
| March 31, 2014 | 84.64% |
| December 31, 2013 | 91.07% |
| September 30, 2013 | 80.48% |
| June 30, 2013 | 87.33% |
| March 31, 2013 | 94.31% |
| December 31, 2012 | 82.93% |
| September 30, 2012 | 89.29% |
| June 30, 2012 | 92.42% |
| March 31, 2012 | 97.25% |
| December 31, 2011 | 84.09% |
| September 30, 2011 | 87.75% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
57.10%
Minimum
Dec 2022
94.16%
Maximum
Dec 2023
82.17%
Average
85.22%
Median
Mar 2021
Gross Profit Margin (Quarterly) Benchmarks
| ANI Pharmaceuticals Inc | 59.42% |
| ADMA Biologics Inc | 42.06% |
| Viking Therapeutics Inc | -- |
| Corcept Therapeutics Inc | 98.61% |
| Palatin Technologies Inc | 95.20% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 7.96% |
| Return on Assets | 6.71% |
| Return on Invested Capital | 7.60% |
| Profit Margin (Quarterly) | 64.72% |
| Operating Margin (Quarterly) | -11.95% |
| Return on Net Operating Assets | 9.83% |